Castle Biosciences, Inc. (CSTL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.13B |
| Enterprise Value | 1.05B |
| P/E Ratio | -52.12 |
| PEG Ratio | 0.52 |
| Price/Sales Ratio | 2.94 |
| Price/Book Ratio | 2.22 |
| Enterprise/Revenue | 2.87 |
| Enterprise/EBITDA | -316.6 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.05 |
| Operating Margin | -0.09 |
AD
Management Effectiveness
| Return On Assets | -0.03 |
| Return On Equity | -0.04 |
Income Statement
| Revenue | 344.23M |
| Revenue/Share | 11.75 |
| Gross Profit | 273.2M |
| EBITDA | 11.34M |
| Net Income | -24.16M |
| Diluted EPS | -0.83 |
Balance Sheet
| Total Cash | 266.81M |
| Total Cash/Share | 8.78 |
| Total Debt | 36.65M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 6.04 |
| Book Value Per Share | 15.46 |
Price History
| 52-Week Change | 44.78 |
| 52-Week High | 44.28 |
| 52-Week Low | 17.72 |
| Moving Average 50 Days | 33.61 |
| Moving Average 200 Days | 28.69 |
Statistics
| Average Volume | 404,121 |
| Shares Outstanding | 30.55M |
| % Held by Institutions | 92.62 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
